FARE Announces Bruce Roberts as Interim CEO During Executive Search

McLean, VA, Jan. 7, 2022—FARE, the world’s leading non-governmental organization engaged in food allergy advocacy and the largest private funder of food allergy research, today announced that Bruce Roberts, FARE’s current Chief Research Strategy and Innovation Officer, will become the interim CEO effective January 14.

FARE CEO Lisa Gable announced her retirement in September 2021, and a transition process and new CEO search has been in process since that time. During her three years as CEO, Ms. Gable created a visionary plan to establish FARE as a world leader in food allergy research, advocacy and education. FARE’s solid foundation and forward thinking in the food allergy community now pave the way for Dr. Roberts’ continued strong leadership into 2022.

“This leadership transition is occurring at an optimum time as we maintain our commitment to programs which not only educate our community and key decision makers, but also focus the majority of our dollars on research,” said Ms. Gable. “I feel confident in handing over the reins to Bruce at this time and am optimistic about FARE’s future – both in 2022 and beyond.” 

Dr. Roberts’ background makes him a natural selection for interim CEO. In his current role at FARE, Roberts leads scientific research initiatives, leveraging his decades of experience in the biomedical industry. Overseeing research efforts and interacting directly with all stakeholders, he plays a pivotal role in uncovering new treatments and driving innovation that will eventually find a cure for this disease. Additionally, he is a regularly published author in the Journal of Immunology, the Journal of Neuroimmunology and other widely respected medical publications.  

“I am honored to follow in Lisa’s footsteps and excited to continue FARE’s mission of advancing forward-thinking projects, messages and strategies that will have a positive impact on the lives of patients,” Dr. Roberts said. “This is indeed an exciting time to be at FARE.” 

David Jaffe, Chairman of the Board for FARE, concluded, “We are extremely thankful to have had Lisa as our CEO for the past three years and equally pleased to welcome Bruce to the helm. Twenty twenty-two looks bright as we continue our legacy of commitment to the food allergy community.”